title: Nicorandil, a potassium channel opener and nitric oxide donor, improves the frequent urination without changing the blood pressure in rats with partial bladder outlet obstruction.
abstract: OBJECTIVE
  It was studied to determine if nicorandil can improve frequent urination in rats with partial bladder outlet obstruction (BOO) without changing the blood pressure.
  
  
  METHODS
  Voiding behavior was observed 6 to 8 d after obstruction in female rats with BOO that loaded 30 ml/kg of water. A drug was administered orally. Changes in systemic blood pressure and heart rate were studied in conscious BOO rats using the tail cuff method.
  
  
  RESULTS
  The voiding frequency was increased and the average voided volume was decreased in BOO rats compared with normal rats. Nicorandil (1 mg/kg), cromakalim (0.1 mg/kg) and isosorbide dinitrate (ISDN; 1000 mg/kg) decreased voiding frequency significantly in BOO rats. Nicorandil also increased the average voided volume significantly. Although cromakalim and ISDN at doses effective at decreasing voiding frequency caused blood pressure to drop, nicorandil at an effective dose did not affect blood pressure and heart rate.
  
  
  CONCLUSIONS
  Nicorandil improved frequent urination without changing the blood pressure. These results suggested that a hybrid of a K(ATP) channel opener and nitric oxide donor, nicorandil was bladder-selective compared with vasculature in BOO rats.
authors.affiliation: Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd, Shizuoka, Japan.
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Sudo
authors.forename: Kenji
authors.initials: K
authors.lastname: Yogo
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Ishizuka
authors.forename: Hideaki
authors.initials: H
authors.lastname: Otsuka
authors.forename: Shigeo
authors.initials: S
authors.lastname: Horie
authors.forename: Keiji
authors.initials: K
authors.lastname: Saito
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D015640:Ion Channel Gating / Q000187:drug effects*; D020108:Nicorandil / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D020030:Nitric Oxide Donors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015221:Potassium Channels / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D001748:Urinary Bladder Neck Obstruction / Q000150:complications* / Q000378:metabolism / Q000652:urine; D014555:Urination Disorders / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control* / Q000652:urine
chemical_list: D020030:Nitric Oxide Donors; D015221:Potassium Channels; D020108:Nicorandil